<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02570464</url>
  </required_header>
  <id_info>
    <org_study_id>2010/147/HP</org_study_id>
    <nct_id>NCT02570464</nct_id>
  </id_info>
  <brief_title>Aortic Cross-Clamping and Systemic Inflammatory Response in Humans: Effect of Ischemic Preconditioning</brief_title>
  <acronym>CLARIS</acronym>
  <official_title>Aortic Cross-Clamping and Systemic Inflammatory Response in Humans: Effect of Ischemic Preconditioning</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multiple organ dysfunction syndrome is a major cause of morbidity and mortality after&#xD;
      abdominal aortic aneurysm (AAA) surgery. It is postulated that aortic cross-clamping during&#xD;
      open AAA repair may cause ischemia-reperfusion (I/R) leading to the systemic releases of&#xD;
      reactive oxygen species (ROS) and inflammatory cytokines which damage distant organs,&#xD;
      including heart, kidney, and lung.&#xD;
&#xD;
      Ischemic preconditioning, first described in cardiac surgery, is a mechanism whereby tissues&#xD;
      exposed to a brief period of nonlethal I/R develop resistance to subsequent ischemic insult.&#xD;
      Remote ischemic preconditioning (RIPC), is a phenomenon whereby brief periods of ischemia&#xD;
      followed by reperfusion in one organ (usually skeletal muscle) provide systemic protection&#xD;
      from prolonged ischemia. The mechanisms through which RIPC confer organ protection remains&#xD;
      unclear.&#xD;
&#xD;
      The hypothesis is that limb RIPC would reduce systemic inflammatory mediators produced by&#xD;
      ischemia-reperfusion and thereby protect the remote organs.&#xD;
&#xD;
      A single-center, prospective, randomized, parallel-group controlled trial is conducted on&#xD;
      patients undergoing elective open infrarenal AAA repair. Written informed consent is obtained&#xD;
      from each participant. The study protocol was reviewed and approved by the Research Ethics&#xD;
      Committee of Rouen, France.&#xD;
&#xD;
      Patients are divided in two groups : the sham-operated control group underwent surgery&#xD;
      without RIPC and the RIPC group : Two cycles of intermittent crossclamping of the common&#xD;
      iliac artery (right or left) with 10 minutes ischemia followed by 10 minutes reperfusion&#xD;
      served as the RIPC stimulus, before prolonged ischemia.&#xD;
&#xD;
      Blood samples are collected for analysis at the following time points: before surgery&#xD;
      (baseline), 1, 3 and 24 h after cross-clamp release (reperfusion). The systemic inflammatory&#xD;
      response is measured using the serum concentrations of TNF-alpha, and IL 1, 4, 6, 10.&#xD;
      Cardiac, renal and pulmonary functions are evaluated with usual biological markers and&#xD;
      clinical monitoring until 28 days after surgery.&#xD;
&#xD;
      Aortic surgery is a perfect clinical model of ischemia-reperfusion which makes it possible to&#xD;
      study the impact of RIPC in humans. This biological approach would help to better understand&#xD;
      the mechanisms underlying this technique.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood TNF-alpha rate</measure>
    <time_frame>24 hours post-surgery</time_frame>
    <description>Blood TNF-alpha rate is measured after reperfusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood lactates rate</measure>
    <time_frame>24 hours post-surgery</time_frame>
    <description>Blood lactates rate is measured after reperfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood I-CAM protein rate</measure>
    <time_frame>24 hours post-surgery</time_frame>
    <description>Blood I-CAM protein rate is measured after reperfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Interleukines 1 rate</measure>
    <time_frame>24 hours post-surgery</time_frame>
    <description>Blood Interleukines 1 rate is measured after reperfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Interleukines 4 rate</measure>
    <time_frame>24 hours post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Interleukines 6 rate</measure>
    <time_frame>24 hours post-surgery</time_frame>
    <description>Blood Interleukines 1 rate is measured after reperfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Interleukines 10 rate</measure>
    <time_frame>24 hours post-surgery</time_frame>
    <description>Blood Interleukines 10 rate is measured after reperfusion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Patients undergoing aortic aneurysm surgery with RIPC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood drawn is done for patient undergoing elective open infrarenal abdominal aortic aneurysm repair surgery with Remote ischemic preconditioning (RIPC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients undergoing aortic aneurysm surgery without RIPC</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Blood drawn is done for patient undergoing elective open infrarenal abdominal aortic aneurysm repair surgery without Remote ischemic preconditioning (RIPC)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote ischemic preconditioning</intervention_name>
    <description>Remote ischemic preconditioning is done for patients undergoing elective open infrarenal abdominal aortic aneurysm repair</description>
    <arm_group_label>Patients undergoing aortic aneurysm surgery with RIPC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood drawn</intervention_name>
    <description>Blood drawn is done for patients undergoing elective open infrarenal abdominal aortic aneurysm repair</description>
    <arm_group_label>Patients undergoing aortic aneurysm surgery with RIPC</arm_group_label>
    <arm_group_label>Patients undergoing aortic aneurysm surgery without RIPC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing elective open infrarenal abdominal aortic aneurysm repair&#xD;
&#xD;
          -  Scheduled surgery&#xD;
&#xD;
          -  Patients aged 30-85 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing endovascular treatment for infrarenal abdominal aortic aneurysm&#xD;
&#xD;
          -  Patients younger than 30 years and older than 85 years&#xD;
&#xD;
          -  pregnant women or nursing mother&#xD;
&#xD;
          -  Adult under guardianship&#xD;
&#xD;
          -  Refusal to sign a consent&#xD;
&#xD;
          -  Patients whose survival at 28 days is unlikely&#xD;
&#xD;
          -  Surgery requiring subphrenic aortic cross-clamping&#xD;
&#xD;
          -  Emergency surgery&#xD;
&#xD;
          -  Patients taking sulfonylureas or Nicorandil&#xD;
&#xD;
          -  Patients having contraindication to clamp iliac arteries&#xD;
&#xD;
          -  Dementia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Melody DUSSEAUX, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <study_first_submitted>October 2, 2015</study_first_submitted>
  <study_first_submitted_qc>October 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2015</study_first_posted>
  <last_update_submitted>May 10, 2016</last_update_submitted>
  <last_update_submitted_qc>May 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

